Results 1 to 10 of about 425,528 (280)

Thyroid-like Follicular Carcinoma of the Right Kidney: A Case Report [PDF]

open access: yesMiddle East Journal of Cancer, 2019
Renal cell carcinoma is responsible for approximately 80% of malignant tumors of the kidney. Clear cell, papillary, and chromophobe forms comprise the most frequent histological subtypes of renal cell carcinoma.
Mohammad Hossein Sanei   +4 more
doaj   +2 more sources

Sohlh2 Inhibits the Malignant Progression of Renal Cell Carcinoma by Upregulating Klotho via DNMT3a

open access: yesFrontiers in Oncology, 2022
BackgroundRenal cell carcinoma is the most common malignant tumor of the kidney. The 5-year survival of renal cell carcinoma with distant metastasis is very low.
Yang Liu   +10 more
doaj   +1 more source

New trends and future prospects of regulatory cell death in renal carcinoma [PDF]

open access: yesZhongguo aizheng zazhi, 2022
Renal cell carcinoma is one of the most common malignancies in genitourinary cancers. In China, the incidence of renal cell carcinoma has been increasing year by year.
CAO Dalong, YE Dingwei
doaj   +1 more source

Metastatic Renal Cell Carcinoma to Duodenum and Pancreas 10 Years After Nephrectomy: A Case Report

open access: yesCase Reports in Clinical Practice, 2023
Renal cell carcinoma (RCC) accounts for 2-3% of the malignant tumors in adult patients. The most common sites of metastasis are the lung, bone, liver and brain respectively.
Mahsa Akbari Oryani   +3 more
doaj   +1 more source

Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and exclusively to the pancreas, suggesting a special role of
Lena Haeberle   +6 more
doaj   +1 more source

LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mTOR Signaling Pathway

open access: yesCells, 2022
ccRCC is highly immunogenic, yet its underlying immune-related molecular mechanisms are unknown. Leukotriene B4 Receptor 1 (LTB4R), a novel immune-related gene associated in our previous research with the prognosis of ccRCC patients, has been found in ...
Xiao Zhang   +4 more
doaj   +1 more source

Case Report: Bilateral Renal Cell Carcinoma With Different Histological and Morphological Features, Clear Cell and Cystic Thyroid-Like Follicular Subtype

open access: yesFrontiers in Oncology, 2021
Thyroid-like follicular renal cell carcinoma is a rare subtype of renal cell carcinoma that has only been recently recognized, as most cases involve a solid tumor in one kidney.
Jinsong Ni   +3 more
doaj   +1 more source

Renal papillary carcinoma developed in a kidney transplant recipient with late IgA-nephropathy [PDF]

open access: yes, 2016
With improvements in immunosuppressive therapy, patient and graft survival in renal transplant recipients have been prolonged. Increasing donor age and patient survival rates have been related to an increase in the number of de novo tumors ...
BERLOCO, Pasquale Bartolomeo   +7 more
core   +1 more source

Current trends in renal cell carcinoma

open access: yesJournal of Medical and Scientific Research, 2014
Kidney cancer is one of the most lethal urological malignancies and surgery was the only treatment of modality a decade ago. Open radical nephrectomy was the procedure of choice for long time for all malignant masses.
Bhardwaj, Gopichand
doaj   +1 more source

Radiogenomics in clear cell renal cell carcinoma: correlations between advanced CT imaging (texture analysis) and microRNAs expression [PDF]

open access: yes, 2019
Purpose: A relevant challenge for the improvement of clear cell renal cell carcinoma management could derive from the identification of novel molecular biomarkers that could greatly improve the diagnosis, prognosis, and treatment choice of these ...
Badia, S.   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy